AMENDMENT NO. 5 TO CONTRACT MANUFACTURING AGREEMENT (Metreleptin SLD)Contract Manufacturing Agreement • June 23rd, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
Contract Type FiledJune 23rd, 2020 Company IndustryTHIS AMENDMENT NO. 5 (the “Amendment”) is made as of October 13 2014 (the “Amendment Effective Date”) by and between Amylin Pharmaceuticals, Inc. with offices at 9360 Towne Centre Drive, San Diego, California 92121 (“Amylin Pharmaceuticals, LLC”) and Sandoz GmbH, with a principal place of business at Biochemiestr. 10, A6250 Kundl, Austria (“Sandoz”).
AMENDMENT NO. 5 TO CONTRACT MANUFACTURING AGREEMENT (Metreleptin SLD)Contract Manufacturing Agreement • May 11th, 2020 • Amryt Pharma PLC • Pharmaceutical preparations
Contract Type FiledMay 11th, 2020 Company IndustryTHIS AMENDMENT NO. 5 (the “Amendment”) is made as of October 13 2014 (the “Amendment Effective Date”) by and between Amylin Pharmaceuticals, Inc. with offices at 9360 Towne Centre Drive, San Diego, California 92121 (“Amylin Pharmaceuticals, LLC”) and Sandoz GmbH, with a principal place of business at Biochemiestr. 10, A6250 Kundl, Austria (“Sandoz”).